News

Pharming Group to Announce Q3 2024 Financial Results Soon

Pharming Group to Announce Q3 2024 Financial Results Soon

Pharming Group Prepares for Upcoming Financial Report

Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is gearing up to share its preliminary financial results for the third quarter of 2024. This release will cover the performance up to September 30, with the announcement scheduled for a Thursday presentation.

Details of the Presentation for Stakeholders

Date and Time of Event

Analysts and investors are invited to join the presentation that will take place at 13:30 CEST/07:30 am EDT. Pharming aims to provide comprehensive insights during this session, allowing stakeholders to understand the company's progress and future trajectory.

How to Participate

To take part in this important conference call, participants need to register in advance. Following registration, attendees will receive unique dial-in information along with a PIN for accessing the call. This ensures a seamless experience for everyone involved.

Engagement Through Webcasts

Live Webcast Information

In addition to the conference call, Pharming encourages everyone to join a live webcast of the presentation. This option is available to enable even broader participation and engagement, ensuring that all interested parties can be informed of the latest developments.

About Pharming Group N.V.

Based in Leiden, the Netherlands, Pharming Group N.V. stands as a prominent figure in the global biopharmaceutical landscape. The company is dedicated to changing lives by focused on rare and life-threatening diseases through innovative protein replacement therapies and precision medicine solutions.

Global Impact and Reach

Pharming’s efforts are felt across more than 30 markets worldwide, including regions such as North America, Europe, the Middle East, Africa, and Asia-Pacific. The company's commitment to patient care showcases its global approach and dedication to medical advancements.

Future Developments at Pharming

Innovative Therapies in the Pipeline

Pharming continues to invest in research and development, striving to enhance its portfolio of therapeutic options. Their focus on small molecules and biologics exemplifies their commitment to delivering cutting-edge treatments that can fundamentally change patient outcomes.

Continuous Engagement with Investors

The relationship between Pharming and its stakeholders is crucial, leading to continuous updates and transparency regarding financial performance and strategic initiatives. This upcoming financial results presentation is an important touchpoint for stakeholders who track the company’s innovations and growth trajectory.

Frequently Asked Questions

When will Pharming Group report its Q3 2024 financial results?

Pharming Group will release its preliminary financial results for Q3 2024 on a Thursday presentation, specific date noted in the press release.

How can investors participate in the presentation?

Investors can join the presentation by registering in advance to receive dial-in details and a unique PIN for access.

What topics will be covered in the conference call?

The conference call will focus on the financial performance and strategic updates of Pharming Group, providing insights for stakeholders.

Is there a live stream option for the presentation?

Yes, Pharming will provide a live webcast of the presentation for broader reach and engagement with a global audience.

What is Pharming's mission as a company?

Pharming Group aims to transform the lives of patients facing rare, debilitating, or life-threatening diseases through innovative therapies and solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Bravo Loans Bridge Gaps in Healthcare Real Estate

Updated Category News Views 70

Mezzanine Financing: A Vital Tool for Healthcare Owners Bravo Property Trust is throwing a lifeline to operators in the healthcare sector and beyond with their mezzanine loans aiming right between the eyes of the financing gap. This isn't just some loan for fun. It's a full-on financial tool designed to give some breathing room to folks owning or operating skilled nursing...

Continue Reading
$4 Million Raised at Miracles for Kids Gala 2026

Updated Category News Views 66

Anthony Geisler's Impactful Philanthropy Ever heard that old chestnut about putting your money where your mouth is? Well, Anthony Geisler, the chap behind Sequel Brands, sure seems to embody it. At the 2026 Miracles for Kids Night of Miracles Gala, he managed to corral over $4 million for families with critically ill kids. That's no chump change, let me tell you. The...

Continue Reading
FuelCell Energy Faces Legal Scrutiny After Stock Plunge

Updated Category News Views 56

FuelCell Energy's Troubling Stock Dive FuelCell Energy's recent plummet isn't just a sobering reality for traders—it comes wrapped in controversy. With NASDAQ:FCEL suffering a 15.69% nosedive after revelations from their fiscal third-quarter results, the ticker’s future hangs precariously. Even for those who've braved the market’s caprices, seeing shares drop $2.68...

Continue Reading
Membrane Chromatography Market Surges with Biologics Boom

Updated Category News Views 0

Another Chapter in Chromatography: What's New? It's like this: membrane chromatography is getting its day in the sun, and it's about time we dive into why it's happening. Projected to scale up from $0.37 billion in 2026 to a neat $0.63 billion by 2031, we’re talking a solid 11.3% compound annual growth rate. It's a tale of tech advancements and rising demand for...

Continue Reading
ACTEC Welcomes 55 New Fellows: A Closer Look

Updated Category News Views 115

Coffee's brewing hot, and so are the stakes at ACTEC, where 55 new Fellows just got the nod. The American College of Trust and Estate Counsel isn't your average club. They've been at this game since 1949, bringing together the finest minds in trusts and estates. But what does this newest batch bring to the table, and why should investors take a moment to notice? A Diverse...

Continue Reading
Geolava, Vaidio, Sensoneo Triumph in Texas Pitch Contest

Updated Category News Views 98

North Texas Lights the Innovation Torch Big moves are happening in North Texas, with a pitch competition that's more than just smoke and mirrors. We're talking about an arena where regional challenges meet cutting-edge solutions, and out of a global mix, Geolava, Vaidio, and Sensoneo snagged the 2026 North Texas Connected Innovation Pitch Contest crown. It's high stakes...

Continue Reading
ACR Poker's $650K Mystery PKO Tournaments Heat Up

Updated Category News Views 0

Final Countdown for ACR Poker’s Halloween Bash When it comes to poker, there might not be a better mix of tension and thrill than a big bounty tournament, and ACR Poker’s $650K Halloween Special Mystery PKOs are right in the thick of it. We’re down to the wire with just the final starting flights left, and the action’s ready to blow the lid off come November 1....

Continue Reading
Keller Joins JC Behavioral Health Council, RCA Shines

Updated Category News Views 50

RCA's Role in Behavioral Health Standards Kendall Keller just grabbed a prime seat at a table that could shape the future of behavioral healthcare in the U.S. Appointed to the Joint Commission’s (JC) Behavioral Health Care & Human Services Advisory Council, Keller isn’t lounging around. Here’s someone with 18 years under her belt, tasked with steering the ship for...

Continue Reading
Circus Circus Vegas Offers Halloween Deals for Families

Updated Category News Views 103

Halloween at Circus Circus: A New Spin on Family Fun Ah, Circus Circus Las Vegas. It's that place that’s managed to blend screaming kids, excited parents, and a flurry of flashing lights into something resembling an amusement park—on the Strip no less. Now, they're turning up the heat for Halloween. Yup, they're rolling out half-price Midway games and Adventuredome...

Continue Reading
Foxconn Shakes Up EV Scene with New Models Unveiled

Updated Category News Views 52

Foxconn Boldly Claims New Ground in EV Market Foxconn's at it again, thumping its chest in the electric vehicle arena with three fresh rides that scream ambition. At the HHTD26 in Taipei, they rolled out the MODEL A+, MODEL K+, and MODEL K—vehicles that not only diversify their portfolio but target segments that rarely see such a jolt. Does it get your gears turning?...

Continue Reading

Top 5 Most Recently Viewed Articles

Hewlett Packard Enterprise and Juniper Networks Stand Firm on Merger

Updated Category News Views 120

Hewlett Packard Enterprise and Juniper Networks Stand Firm Hewlett Packard Enterprise (NYSE:HPE) and Juniper Networks, Inc. (NYSE:JNPR) have publicly expressed their strong disapproval regarding the U.S. Department of Justice's recent move to block their impending acquisition. Both companies assert that the government's position is fundamentally misguided and look forward...

Continue Reading
Essity's Strategic Repurchase of Class B Shares Explained

Updated Category News Views 65

Essity’s Class B Shares Buyback Overview Recently, Essity Aktiebolag declared its intention to repurchase a significant quantity of its Class B shares. This initiative reflects the company's commitment to enhance its shareholders' value while efficiently managing capital allocation. The buyback program announced earlier provides a structured approach aimed at achieving...

Continue Reading
24 Seven Achieves Recognition on Forbes 2025 List of Best Firms

Updated Category News Views 253

24 Seven Achieves Recognition on Forbes 2025 List of Best Firms 24 Seven, a leading firm in the marketing, creative, and digital talent solutions space, has once again made waves in the industry by appearing on the prestigious list of America’s Best Recruiting and Temporary Staffing Firms for 2025. This significant recognition highlights the exemplary standards...

Continue Reading
Valneva's Chikungunya Vaccine Sees Strong Results in Children

Updated Category News Views 148

Positive Results from Valneva's Chikungunya Vaccine Trial Valneva SE (NASDAQ: VALN; Euronext Paris: VLA), a leading specialty vaccine company, has reported encouraging findings from its Phase 2 clinical trial for its chikungunya vaccine, IXCHIQ. This trial focused on assessing the safety and immunogenicity of two distinct dose levels of this single-shot vaccine among...

Continue Reading
Recognizing Trailblazers: 2025 WISE Awards Nominations Open

Updated Category News Views 368

Nominations Open for 2025 WISE Awards by Smart Energy Decisions Smart Energy Decisions (SED), a pivotal professional network focused on empowering businesses to make informed energy choices, has officially opened the nominations for the esteemed 2025 WISE (Women in Smart Energy) Awards. These awards aim to honor the groundbreaking contributions of women in the energy...

Continue Reading